COVID-19 | Disease | FDA | Therapeutics
City of Hope doctors lead novel clinical trial to treat cancer patients with COVID-19
On Sept. 1, 2020, City of Hope announced that it was investigating an innovative treatment for cancer patients…
FDA Approves Tocilizumab for Treatment of Rheumatoid Arthritis
On Jan. 11, 2010, the U.S. Food and Drug Administration (FDA) approved Genentech’s tocilizumab (Actemra) for the treatment…
Rheumatoid Arthritis gene was discovered
On Nov. 8, 2007, researchers from Brigham and Women’s and MIT’s Broad Institute and Harvard discovered a gene…
Biotechnology | Disease | FDA | Life Science News | Medicine | Therapeutics
Long-term efficacy and safety of etanercept was found in children with polyarticular-course juvenile rheumatoid arthritis
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
Immunex received FDA approval to market Enbrel for treatment of moderate to severe rheumatoid arthritis
On Nov. 10, 1998, Immunex announced that ENBREL(tm) (etanercept) had received approval from the U.S. Food and Drug…
Immunex dedicated its new manufacturing and development center
In 1998, Immunex dedicated its new manufacturing and development center. The 100,000 square foot complex broke ground in…
Drs. Edward C Kendall and Philip S Hench at the Mayo Clinic, shared the Nobel Prize in medicine
In 1950, Drs. Edward C. Kendall and Philip S. Hench at the Mayo Clinic, along with Tadeus Reichstein,…
A patient at Saint Marys Hospital received the first injection of Compound E (Cortisone) for rheumatoid arthritis
On Sept. 21, 1948, a 28-year-old woman at Saint Marys Hospital (Mayo Clinic) in Rochester, MN received the…